View in EDS

Fragment optimization and elaboration strategies - the discovery of two lead series of PRMT5/MTA inhibitors from five fragment hits.

Saved in:
Bibliographic Details
Title: Fragment optimization and elaboration strategies - the discovery of two lead series of PRMT5/MTA inhibitors from five fragment hits.
Authors: Smith CR; Mirati Therapeutics San Diego California 92121 USA smithc@mirati.com kulyks@mirati.com., Kulyk S; Mirati Therapeutics San Diego California 92121 USA smithc@mirati.com kulyks@mirati.com., Ahmad MUD; ZoBio BV J. H. Oortweg 19 2333 CH Leiden Netherlands., Arkhipova V; ZoBio BV J. H. Oortweg 19 2333 CH Leiden Netherlands., Christensen JG; Mirati Therapeutics San Diego California 92121 USA smithc@mirati.com kulyks@mirati.com., Gunn RJ; Mirati Therapeutics San Diego California 92121 USA smithc@mirati.com kulyks@mirati.com., Ivetac A; Mirati Therapeutics San Diego California 92121 USA smithc@mirati.com kulyks@mirati.com., Ketcham JM; Mirati Therapeutics San Diego California 92121 USA smithc@mirati.com kulyks@mirati.com., Kuehler J; Mirati Therapeutics San Diego California 92121 USA smithc@mirati.com kulyks@mirati.com., Lawson JD; Mirati Therapeutics San Diego California 92121 USA smithc@mirati.com kulyks@mirati.com., Thomas NC; Mirati Therapeutics San Diego California 92121 USA smithc@mirati.com kulyks@mirati.com., Wang X; Mirati Therapeutics San Diego California 92121 USA smithc@mirati.com kulyks@mirati.com., Marx MA; Mirati Therapeutics San Diego California 92121 USA smithc@mirati.com kulyks@mirati.com.
Source: RSC medicinal chemistry [RSC Med Chem] 2022 Sep 27; Vol. 13 (12), pp. 1549-1564. Date of Electronic Publication: 2022 Sep 27 (Print Publication: 2022).
Publication Type: Journal Article
Journal Info: Publisher: Royal Society of Chemistry Country of Publication: England NLM ID: 101759460 Publication Model: eCollection Cited Medium: Internet ISSN: 2632-8682 (Electronic) Linking ISSN: 26328682 NLM ISO Abbreviation: RSC Med Chem Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 36545438
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Fragment optimization and elaboration strategies - the discovery of two lead series of PRMT5/MTA inhibitors from five fragment hits.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Smith+CR%22">Smith CR</searchLink>; Mirati Therapeutics San Diego California 92121 USA smithc@mirati.com kulyks@mirati.com.<br /><searchLink fieldCode="AU" term="%22Kulyk+S%22">Kulyk S</searchLink>; Mirati Therapeutics San Diego California 92121 USA smithc@mirati.com kulyks@mirati.com.<br /><searchLink fieldCode="AU" term="%22Ahmad+MUD%22">Ahmad MUD</searchLink>; ZoBio BV J. H. Oortweg 19 2333 CH Leiden Netherlands.<br /><searchLink fieldCode="AU" term="%22Arkhipova+V%22">Arkhipova V</searchLink>; ZoBio BV J. H. Oortweg 19 2333 CH Leiden Netherlands.<br /><searchLink fieldCode="AU" term="%22Christensen+JG%22">Christensen JG</searchLink>; Mirati Therapeutics San Diego California 92121 USA smithc@mirati.com kulyks@mirati.com.<br /><searchLink fieldCode="AU" term="%22Gunn+RJ%22">Gunn RJ</searchLink>; Mirati Therapeutics San Diego California 92121 USA smithc@mirati.com kulyks@mirati.com.<br /><searchLink fieldCode="AU" term="%22Ivetac+A%22">Ivetac A</searchLink>; Mirati Therapeutics San Diego California 92121 USA smithc@mirati.com kulyks@mirati.com.<br /><searchLink fieldCode="AU" term="%22Ketcham+JM%22">Ketcham JM</searchLink>; Mirati Therapeutics San Diego California 92121 USA smithc@mirati.com kulyks@mirati.com.<br /><searchLink fieldCode="AU" term="%22Kuehler+J%22">Kuehler J</searchLink>; Mirati Therapeutics San Diego California 92121 USA smithc@mirati.com kulyks@mirati.com.<br /><searchLink fieldCode="AU" term="%22Lawson+JD%22">Lawson JD</searchLink>; Mirati Therapeutics San Diego California 92121 USA smithc@mirati.com kulyks@mirati.com.<br /><searchLink fieldCode="AU" term="%22Thomas+NC%22">Thomas NC</searchLink>; Mirati Therapeutics San Diego California 92121 USA smithc@mirati.com kulyks@mirati.com.<br /><searchLink fieldCode="AU" term="%22Wang+X%22">Wang X</searchLink>; Mirati Therapeutics San Diego California 92121 USA smithc@mirati.com kulyks@mirati.com.<br /><searchLink fieldCode="AU" term="%22Marx+MA%22">Marx MA</searchLink>; Mirati Therapeutics San Diego California 92121 USA smithc@mirati.com kulyks@mirati.com.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101759460%22">RSC medicinal chemistry</searchLink> [RSC Med Chem] 2022 Sep 27; Vol. 13 (12), pp. 1549-1564. <i>Date of Electronic Publication: </i>2022 Sep 27 (<i>Print Publication: </i>2022).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Royal+Society+of+Chemistry%22">Royal Society of Chemistry </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101759460 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>2632-8682 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2226328682%22">26328682 </searchLink><i>NLM ISO Abbreviation: </i>RSC Med Chem <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36545438
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1039/d2md00163b
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1549
    Titles:
      – TitleFull: Fragment optimization and elaboration strategies - the discovery of two lead series of PRMT5/MTA inhibitors from five fragment hits.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Smith CR
      – PersonEntity:
          Name:
            NameFull: Kulyk S
      – PersonEntity:
          Name:
            NameFull: Ahmad MUD
      – PersonEntity:
          Name:
            NameFull: Arkhipova V
      – PersonEntity:
          Name:
            NameFull: Christensen JG
      – PersonEntity:
          Name:
            NameFull: Gunn RJ
      – PersonEntity:
          Name:
            NameFull: Ivetac A
      – PersonEntity:
          Name:
            NameFull: Ketcham JM
      – PersonEntity:
          Name:
            NameFull: Kuehler J
      – PersonEntity:
          Name:
            NameFull: Lawson JD
      – PersonEntity:
          Name:
            NameFull: Thomas NC
      – PersonEntity:
          Name:
            NameFull: Wang X
      – PersonEntity:
          Name:
            NameFull: Marx MA
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 27
              M: 09
              Text: 2022 Sep 27
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-electronic
              Value: 2632-8682
          Numbering:
            – Type: volume
              Value: 13
            – Type: issue
              Value: 12
          Titles:
            – TitleFull: RSC medicinal chemistry
              Type: main
ResultId 1